Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications.

These findings show that certain concomitant medications and cannabis constituents may be associated with AE incidence when initiating medicinal cannabis. These potential pharmacokinetic and pharmacodynamic interactions require further study to develop guidance for prescribers and pharmacists.